Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 1, 2008, Pages 26-31

  Daniil, Zoe D ^a   Papageorgiou, Evangelia ^a   Koutsokera, Agela ^a   Kostikas, Konstantinos ^a   Kiropoulos, Theodoros ^a   Papaioannou, Andriana I ^a   Gourgoulianis, Konstantinos I ^a  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Idiopathic pulmonary fibrosis; Lung function; Medical research council chronic dyspnea scale; Oxidative stress

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LUNG FUNCTION; MALE; MEASUREMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SEROLOGY; SPECTROPHOTOMETRY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY FIBROSIS; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; SERUM; SEVERITY OF ILLNESS INDEX;

EID: 38049079133     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2006.10.005     Document Type: Article

References (34)

1. American Thoracic Society. European Respiratory Society, American College of Chest Physicians. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161 (2000) 646-664
2. Gross T.J., and Hunninghake G.W. Idiopathic pulmonary fibrosis. N Engl J Med 345 (2001) 517-525
3. Keogh B.A., and Crystal R.G. Alveolitis: the key to the interstitial lung disorders. Thorax 37 (1982) 1-10
4. Selman M., King T.E., and Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134 (2001) 136-151
5. Katzenstein A.L. Pathogenesis of "fibrosis" in interstitial pneumonia: an electron microscopic study. Hum Pathol 16 (1985) 1015
6. Bellocq A., Azoulay E., Marullo S., Flahault A., Phillipe C., Cadranel J., and Baud L. Reactive oxygen and nitrogen intermediates increase transforming growth factor beta 1 release from human epithelial alveolar cells through two different mechanisms. Am J Respir Cell Mol Biol 21 (1999) 128-136
7. Hagimoto N., Kuwano K., Inoshima I., Yoshimi M., Nakamura N., Fujita M., Maeyama T., and Hara N. TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J Immunol 168 (2002) 6470
8. Borok Z., Buhl R., Grimes G.J., Bokser A.D., Hubbard R.C., Holroyd K.J., Roum J.H., Czerski D.B., Cantin A.M., and Crystal R.G. Effect of glutathione aerosol on oxidant antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 338 (1991) 215-216
9. Cantin A.M., North S.L., Fells G.A., Hubbard R.C., and Crystal R.G. Oxidant mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest 79 (1987) 1665-1673
10. Strausz J., Muller Quernheim J., Steppling H., and Ferlinz R. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 141 (1990) 124-129
11. Jack C.I., Jackson M.J., Johnston I.D., and Hind C.R. Serum indicators of free radical activity in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 153 (1996) 1918-1923
12. Rahman I., Skwarska E., Henry M., Davis M., Davis M., O'Connor C.M., Fitzgerald M.X., Greening A., and MacNee W. Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radical Biol Med 27 (1999) 60-68
13. Quanjer Ph.H., Tammeling G.J., Cotes J.E., Pederson O.F., Peslin R., and Yernault J.C. Lung volumes and forced ventilatory flows. Report working party, Standardization of lung function tests, European Community for steel and coal. Official Statement of the European respiratory Society. Eur Respir J 6 Suppl. 16 (1993) 5-40
14. Cotes J.E., Chinn D.J., Quanjer Ph.H., Roca J., and Yernault J.C. Standardization of the measurement of transfer factor (Diffusing Capacity). Report working party, Standardization of lung function tests, European Community for steel and coal. Official Statement of the European Respiratory Society. Eur Respir J 6 Suppl. 16 (1993) 41-52
15. Eltayara L., Becklake M.R., Volta C.A., and Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154 (1996) 1726-1734
16. Buonocore G., Perrone S., Longini M., Vezzosi P., Marzocchi B., Paffetti P., and Bracci R. Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr Res 47 (2000) 221-224
17. Cesarone M.R., Belcaro G., Carratelli M., Cornelli U., DeSanctis M.T., Incandela L., and Venniker R. A simple test to monitor oxidative stress. Int Angiol 18 (1999) 127-130
18. Ternay A.L., and Sorokin V. Redox, Radicals and antioxidants. In: Baskin S.I., and HS (Eds). Oxidants, Antioxidants, and Free Radicals (1997), Taylor & Francis, Washington, DC 1-21
19. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
20. Rahman I., Morrison D., Donaldson K., and MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 154 (1996) 1055-1060
21. Repine J.E., Bast A., and Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 156 (1997) 341-357
22. Wood L.G., Garg M.L., Simpson J.L., Mori T.A., Croft K.D., Wark P.A., and Gibson P.G. Induced Sputum 8-Isoprostane Concentrations in Inflammatory Airway Diseases. Am J Respir Crit Care Med 171 (2005) 426-430
23. Lenz A.G., Costabel U., and Maier K.L. Oxidized BAL fluid proteins in patients with interstitial lung diseases. Eur Respir J 9 (1996) 307-312
24. Kostikas K., Papatheodorou G., Psathakis K., Panagou P., and Loukidis S. Oxidative stress in expired breath condensate of patients with COPD. Chest 124 (2003) 1373-1380
25. Paredi P., Kharitonov S.A., and Barnes P.J. Analysis of expired air for oxidation products. Am J Respir Crit Care Med 166 (2002) S31-S37
26. Crapo J.D. Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol 48 (1986) 721-731
27. Montuschi P., Ciabattoni G., Paredi P., Pantelidis P., du Bois R., Kharitinov A., and Barnes P. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 158 (1998) 1524-1527
28. Saleh D Barnes P.J., and Giaid A. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155 (1997) 1763-1769
29. Iamele L., Fiocchi R., and Vernocchi A. Evaluation of an automated spectrophotometric assay for reactive oxygen metabolites in serum. Clin Chem Lab Med 40 (2002) 673-676
30. Borzi R.M., Grigolo B., Meliconi R., Fasano L., Sturani C., Fabbri M., Porstmann T., and Facchini A. Elevated serum superoxide dimutase levels correlate with disease severity and neutrophil degranulation in idiopathic pulmonary fibrosis. Clin Sci 85 (1993) 353-359
31. Noble P.W., and Homer R.J. Idiopathic pulmonary fibrosis: new insights into pathogenesis. Clin Chest Med 25 (2004) 749-758
32. Cantin A.M., Hubbard R.C., and Crystal R.G. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 139 (1989) 370-372
33. Crystal R.G. Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention. Am J Med 91 (1991) 39S-44S
34. Demedts M., Behr J., Bulh R., et al. for the IFIGENIA Study Group. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353 (2005) 2229-2242